A Medicated Empire : The Pharmaceutical Industry and Modern Japan / Timothy M. Yang
Frontmatter -- Contents -- Acknowledgments -- Note to the Reader -- Introduction -- Part I. The Drug Industry, Entrepreneurship, and the State -- 1. A Strategic Industry -- 2. The Supposed Self-Made Man and His Company -- Part II. Marketing Medicines and Medicinal Infrastructures -- 3. Marketing a Culture of Self-Medication -- 4. Medicinal Infrastructures and Medical Missionaries -- Part III. The Opium Empire -- 5. The Scandal of Opium (and the Colonial Exception) -- 6. Things Fall Apart -- Part IV. Science, Self-Sufficiency, and Wartime Mobilization -- 7. Selling the Science of Quinine Self-Sufficiency -- 8. War and Drugs -- Epilogue -- Notes -- Bibliography -- Index -- Selected Titles.
In A Medicated Empire, Timothy M. Yang explores the history of Japan's pharmaceutical industry in the early twentieth century through a close account of Hoshi Pharmaceuticals, one of East Asia's most influential drug companies from the late 1910s through the early 1950s. Focusing on Hoshi's connections to Japan's emerging nation-state and empire, and the ways in which it embraced an ideology of modern medicine as a humanitarian endeavor for greater social good, Yang shows how the industry promoted a hygienic, middle-class culture that was part of Japan's national development and imperial expansion. Yang makes clear that the company's fortunes had less to do with scientific breakthroughs and medical innovations than with Japan's web of social, political, and economic relations. He lays bare Hoshi's business strategies and its connections with politicians and bureaucrats, and he describes how public health authorities dismissed many of its products as placebos at best and poisons at worst. Hoshi, like other pharmaceutical companies of the time, depended on resources and markets opened up, often violently, through colonization. Combining global histories of business, medicine, and imperialism, A Medicated Empire shows how the development of the pharmaceutical industry simultaneously supported and subverted regimes of public health at home and abroad.
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
[2021] |
|---|---|
| Erschienen: |
Ithaca, NY: Cornell University Press ; 2021 |
| Reproduktion: |
[Online-Ausgabe] |
|---|---|
| Weitere Ausgaben: |
Erscheint auch als Druck-Ausgabe: A medicated empire |
| Reihe: |
Studies of the Weatherhead East Asian Institute, Columbia University |
|---|
| Sprache: |
Englisch In English |
|---|
| Beteiligte Personen: |
Yang, Timothy M [VerfasserIn] |
|---|
| Links: |
www.degruyter.com [lizenzpflichtig] |
|---|
| ISBN: |
|---|
| BKL: | |
|---|---|
| Themen: |
Arzneimittelwirtschaft |
| Beschreibung: |
Mode of access: Internet via World Wide Web. |
|---|
| Umfang: |
1 Online-Ressource (354 p) ; 25 b&w halftones, 3 b&w line drawings |
|---|
| doi: |
10.1515/9781501756269 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1761836528 |
|---|
| LEADER | 01000cam a22002652 4500 | ||
|---|---|---|---|
| 001 | 1761836528 | ||
| 003 | DE-627 | ||
| 005 | 20240125204136.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210702s2021 xxu|||||o 00| ||eng c | ||
| 020 | |a 9781501756269 |9 978-1-5017-5626-9 | ||
| 024 | 7 | |a 10.1515/9781501756269 |2 doi | |
| 035 | |a (DE-627)1761836528 | ||
| 035 | |a (DE-599)KEP066155053 | ||
| 035 | |a (DE-B1597)571911 | ||
| 035 | |a (EBP)066155053 | ||
| 040 | |a DE-627 |b eng |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XD-US | ||
| 050 | 0 | |a HD9672.J29 | |
| 050 | 0 | |a HD9672.J29 | |
| 072 | 7 | |a HIS021000 |2 bisacsh | |
| 084 | |a 15.80 |2 bkl | ||
| 084 | |a 44.01 |2 bkl | ||
| 084 | |a 15.09 |2 bkl | ||
| 100 | 1 | |a Yang, Timothy M |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Medicated Empire |b The Pharmaceutical Industry and Modern Japan |c Timothy M. Yang |
| 264 | 1 | |a Ithaca, NY |b Cornell University Press |c [2021] | |
| 300 | |a 1 Online-Ressource (354 p) |b 25 b&w halftones, 3 b&w line drawings | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Studies of the Weatherhead East Asian Institute, Columbia University | |
| 506 | 1 | |a Restricted Access |e Controlled Vocabulary for Access Rights |u http://purl.org/coar/access_right/c_16ec |f online access with authorization |2 star | |
| 520 | |a Frontmatter -- Contents -- Acknowledgments -- Note to the Reader -- Introduction -- Part I. The Drug Industry, Entrepreneurship, and the State -- 1. A Strategic Industry -- 2. The Supposed Self-Made Man and His Company -- Part II. Marketing Medicines and Medicinal Infrastructures -- 3. Marketing a Culture of Self-Medication -- 4. Medicinal Infrastructures and Medical Missionaries -- Part III. The Opium Empire -- 5. The Scandal of Opium (and the Colonial Exception) -- 6. Things Fall Apart -- Part IV. Science, Self-Sufficiency, and Wartime Mobilization -- 7. Selling the Science of Quinine Self-Sufficiency -- 8. War and Drugs -- Epilogue -- Notes -- Bibliography -- Index -- Selected Titles | ||
| 520 | |a In A Medicated Empire, Timothy M. Yang explores the history of Japan's pharmaceutical industry in the early twentieth century through a close account of Hoshi Pharmaceuticals, one of East Asia's most influential drug companies from the late 1910s through the early 1950s. Focusing on Hoshi's connections to Japan's emerging nation-state and empire, and the ways in which it embraced an ideology of modern medicine as a humanitarian endeavor for greater social good, Yang shows how the industry promoted a hygienic, middle-class culture that was part of Japan's national development and imperial expansion. Yang makes clear that the company's fortunes had less to do with scientific breakthroughs and medical innovations than with Japan's web of social, political, and economic relations. He lays bare Hoshi's business strategies and its connections with politicians and bureaucrats, and he describes how public health authorities dismissed many of its products as placebos at best and poisons at worst. Hoshi, like other pharmaceutical companies of the time, depended on resources and markets opened up, often violently, through colonization. Combining global histories of business, medicine, and imperialism, A Medicated Empire shows how the development of the pharmaceutical industry simultaneously supported and subverted regimes of public health at home and abroad | ||
| 533 | |a [Online-Ausgabe] | ||
| 538 | |a Mode of access: Internet via World Wide Web. | ||
| 546 | |a In English | ||
| 650 | 7 | |8 1.1\x |a Pharmaindustrie |0 (DE-627)091383137 |0 (DE-2867)13002-3 |2 stw | |
| 650 | 7 | |8 1.2\x |a Arzneimittel |0 (DE-627)091383145 |0 (DE-2867)14728-1 |2 stw | |
| 650 | 7 | |8 1.3\x |a Wirtschaftsgeschichte |0 (DE-627)091400961 |0 (DE-2867)15706-6 |2 stw | |
| 650 | 7 | |8 1.4\x |a Unternehmensgeschichte |0 (DE-627)091360099 |0 (DE-2867)12046-2 |2 stw | |
| 650 | 7 | |8 1.5\x |a Japan |0 (DE-627)091369282 |0 (DE-2867)17568-3 |2 stw | |
| 650 | 4 | |8 1.6\x |a Hoshi Pharmaceuticals |2 stw | |
| 650 | 0 | |a Pharmaceutical industry |z Japan |x History |y 20th century | |
| 650 | 4 | |a Business (General) | |
| 650 | 4 | |a Medicine & Medical Issues | |
| 650 | 4 | |a Asian Studies | |
| 650 | 4 | |a HISTORY / Asia / Japan | |
| 689 | 0 | 0 | |D g |0 (DE-588)4028495-5 |0 (DE-627)104585102 |0 (DE-576)208977503 |a Japan |2 gnd |
| 689 | 0 | 1 | |D s |0 (DE-588)4418449-9 |0 (DE-627)213732858 |0 (DE-576)212239848 |a Arzneimittelwirtschaft |2 gnd |
| 689 | 0 | 2 | |D s |0 (DE-588)4045696-1 |0 (DE-627)106200690 |0 (DE-576)209066393 |a Pharmazeutische Industrie |2 gnd |
| 689 | 0 | 3 | |D s |0 (DE-588)4061963-1 |0 (DE-627)104665327 |0 (DE-576)209142006 |a Unternehmen |2 gnd |
| 689 | 0 | 4 | |A z |2 gnd |a Geschichte 1900-1950 |
| 689 | 0 | |5 (DE-627) | |
| 776 | 1 | |z 9781501756245 |c : print | |
| 776 | 0 | 8 | |i Erscheint auch als |n print |z 9781501756245 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Yang, Timothy M., 1981 - |t A medicated empire |d Ithaca : Cornell University Press, 2021 |h xvi, 335 Seiten |w (DE-627)1737702185 |z 9781501756245 |
| 856 | 4 | 0 | |u https://www.degruyter.com/isbn/9781501756269 |m X:GRUY |x Verlag |z lizenzpflichtig |
| 856 | 4 | 0 | |u https://doi.org/10.1515/9781501756269?locatt=mode:legacy |m X:GRUY |x Resolving-System |z lizenzpflichtig |
| 856 | 4 | 2 | |u https://www.degruyter.com/cover/covers/9781501756269.jpg |m X:GRUY |x Verlag |3 Cover |
| 856 | 4 | 2 | |u https://www.degruyter.com/document/cover/isbn/9781501756269/original |m X:GRUY |x Verlag |3 Cover |
| 912 | |a EBA-CL-HICS | ||
| 912 | |a EBA-EBKALL | ||
| 912 | |a EBA-ECL-HICS | ||
| 912 | |a EBA-EEBKALL | ||
| 912 | |a EBA-ESSHALL | ||
| 912 | |a EBA-PPALL | ||
| 912 | |a EBA-SSHALL | ||
| 912 | |a GBV-deGruyter-alles | ||
| 912 | |a PDA11SSHE | ||
| 912 | |a PDA13ENGE | ||
| 912 | |a PDA17SSHEE | ||
| 912 | |a PDA5EBK | ||
| 912 | |a ZDB-23-DEG |b 2021 | ||
| 912 | |a ZDB-23-DGG |b 2021 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a ISIL_DE-705 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_72 | ||
| 912 | |a ISIL_DE-35 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a ISIL_DE-517 | ||
| 936 | b | k | |a 15.80 |j Japan |x Geschichte |q SEPA |0 (DE-627)181571668 |
| 936 | b | k | |a 44.01 |j Geschichte der Medizin |q SEPA |0 (DE-627)106409638 |
| 936 | b | k | |a 15.09 |j Wirtschaftsgeschichte |q SEPA |0 (DE-627)181569663 |
| 951 | |a BO | ||
| 953 | |2 045F |a 338.7/616151095209041 | ||
| 980 | |2 60 |1 01 |x 0705 |b 4017615619 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |k Nur für Angehörige der HSU: Volltextzugang von außerhalb des Campus mit Anmeldung über Shibboleth mit Ihrer Bibliothekskennung |y z |z 08-12-21 | ||
| 980 | |2 72 |1 01 |x 0035 |b 3956310578 |h OLR-DG-PDA11SSHE |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 20-07-21 | ||
| 980 | |2 285 |1 01 |x 0517 |b 3991722496 |h OLR-DEG |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y z |z 20-10-21 | ||
| 981 | |2 60 |1 01 |x 0705 |r https://doi.org/10.1515/9781501756269?locatt=mode:legacy | ||
| 981 | |2 72 |1 01 |x 0035 |r http://hanproxy.gwlb.de/han/degruyter/www.degruyter.com/isbn/9781501756269 | ||
| 981 | |2 285 |1 01 |x 0517 |r https://doi.org/10.1515/9781501756269?locatt=mode:legacy | ||
| 985 | |2 72 |1 01 |x 0035 |a ebk1 | ||
| 995 | |2 72 |1 01 |x 0035 |a OLR-DG-PDA11SSHE | ||
| 995 | |2 285 |1 01 |x 0517 |a OLR-DEG | ||